Navigation Links
Welch Allyn Video Direct Ophthalmoscope (Head Only)

ProductsWelch Allyn Video Direct Ophthalmoscope (Head Only)
Company Welch Allyn Medical Products
Item Welch Allyn Video Direct Ophthalmoscope (Head Only)
Features 
  • Coaxial Optical System offers you easier entry into an undilated pupil and wider field of view.
  • Diopter values are easily visible and not occluded -- a common problem with other video direct ophthalmoscopes.
  • Camera and instrument are automatically aligned when connected.
  • High Pressure Xenon (Halogen HPX)illumination provides the whitest, brightest light available.
  • 6 aperture selections.
  • Red-free, polarizing filter.
  • Diopter selections from -25 to +40 in single increments.
    • Description Seeing clearly into the future of medicine. Using the same technology as in our optical versions, the Video Ophthalmoscope offers unparalleled video images of the inner eye for better patient education, teaching applications, and the far-reaching benefits of telemedicine.
    Info Welch Allyn Medical Products
    Customer Service: (800) 535-6663
    Web site: http://www.welchallyn.com/medical/

    Related medicine products :

    1. Welch Allyn PanOptic Ophthalmoscope with Cobalt-Blue Filter and Corneal Viewing Lens
    2. Welch Allyn PanOptic Ophthalmoscope
    3. Welch Allyn Suresight™ Vision Screener (English)
    4. Welch Allyn 2.5v PocketScope Ophthalmoscope with AA battery handle in soft carrying case
    5. Welch Allyn 2.5v PocketScope Ophthalmoscope with AA battery handle
    6. Welch Allyn 2.5v PocketScope Ophthalmoscope (without Handle)
    7. Welch Allyn Prestige Coaxial-plus Ophthalmoscope (Head Only)
    8. Welch Allyn Binocular Indirect Ophthalmoscope with Diffuser Filter
    9. Welch Allyn 3.5v AutoStep Coaxial Ophthalmoscope Head Only
    10. Welch Allyn Wall/Desk Power Source for Binocular Indirect Ophthalmoscope
    11. OLY-220 CCD Color Video Camera
    ...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
    ...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
    ...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
    ...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
    Medicine Products:
    (Date:10/7/2008)... Moores Cancer Center at the University of Califor...ave off the relentless march of advanced lung canc...r vaccine. While many vaccines attempt to pump up ...accine, Lucanix, is genetically engineered to also...em-suppressing activities. , The first patients ...
    (Date:10/7/2008)...ment of planned bequest comes at stem cell symposi...re/ -- Just over one year,ago, retail pioneer A. A...University of Michigan, to endow a new research in...nting human disease., Today, at the institute,s f... he will bequeath an additional $22 million to the...
    (Date:10/7/2008)...0 PEOPLE ACROSS THE NATION HAVE SAID ,I VOTE FOR T...S, Oct. 7 /PRNewswire/ -- To aid and help educate ... positions of presidential candidates,Senators Joh...ancer issues,the Susan G. Komen for the Cure(R) A...ces available on its web site --, http://www.IVote...
    (Date:10/7/2008)... Wyndstorm Corporation ( www.wyndstorm.com ) ...ompany, announced a key win with Muve, Inc. ( www....plan program design to promote Muve,s activity-bas...project will ultimately help Muve,s corporate clie...oyees via interactive messaging, rewards programs,...
    Breaking Medicine News(10 mins):Health News:Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center 2Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 2Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 3
    ...claim to the highest autism rate in America, have ...to autism and provide lifetime care for those wit...utism, the largest so far, has found that about 1 ...est rate 1 in 94 children found in New Jersey. ...
    ...tronic nose device which may be used to diagnose t...s at Leiden University Medical Center in the Nethe... a newer version of a sensor that has been used in...es, contains chemical vapour sensors that react to...
    ...male impotence drug Viagra may be useful for treat...r the treatment of high blood pressure and angina,...levels of a naturally-occurring compound, cyclic g...GMP). In the brain, cGMP has a vital function in ...
    ...that topical application of a gel made from platel...ds heal more quickly and completely . Recent inno... into a concentrated plasma rich in platelets (par...), and then to an autologous (from the patients ow...
    Other Medicine News:Health News:American State Lawmakers Make Moves To Tackle Autism 2Health News:Electronic Nose to Diagnose the Severity of Asthma 2Health News:Gel Made of Patients Own Platelets may Speed Up Wound Healing 2
    (Date:10/7/2008).../- CEL-SCI Corporation,(NYS... a Material Transfer,Agreement (MTA) with the Nati...and the laboratory of Dr. Francesco M. Marincola, ...s to the tumor microenvironment,caused by CEL-SCI,...f of,the Infectious Disease and Immunogentics Sect...
    (Date:10/7/2008)...d Today at ACG Annual Scientific Meeting -, ORLAN...d,Pharmaceuticals, Inc. (formerly Microbia, Inc.) ...announced the presentation of results from a Phase...acy in 420 patients with,irritable bowel syndrome ...dicates that once- daily oral dosing of linaclotid...
    (Date:10/7/2008)...ghlighting CIMZIA,s long-term benefits and value i...ented at American College,of Gastroenterology (ACG... Data from two studies,presented this week by UCB ...Annual Meeting demonstrate that CIMZIA(R) (certoli...Tumor Necrosis Factor alpha) - provides,sustained ...
    (Date:10/7/2008)...hort Enrolled in Stage A of Trial Assessing Regime...n and Paclitaxel -, TUSTIN, Calif., Oct. 7 /PRNew.... (Nasdaq: PPHM ), a clinical stage biopharmaceut...the treatment of cancer and,hepatitis C virus (HCV...,enrollment in the first stage of a Phase II trial...
    Breaking Medicine Technology:CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 2CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 2CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 3CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 4CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 5CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 6CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 7CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 8CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohn's Disease Patients 9Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 2Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 3Peregrine Pharmaceuticals Completes Patient Enrollment in First Stage of Its Second Bavituximab Phase II Breast Cancer Trial 4U S Research Funding Continues to Flatten as U S Health Costs Climb in August 31 Science 258 1U S Research Funding Continues to Flatten as U S Health Costs Climb in August 31 Science 258 2Cepheid to Present at Thomas Weisel Partners Healthcare Conference 282 1Cepheid to Present at Thomas Weisel Partners Healthcare Conference 282 2Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference 280 1Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference 280 2Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference 280 3Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference 278 1Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference 278 2